JB Chemicals & Pharmaceuticals Ltd - Stock Price

As on22 Oct 2021
  • NSE : JBCHEPHARM
  • BSE : 506943
  • ISIN CODE : INE572A01028
  • Industry : Pharmaceuticals & Drugs
  • House : Private
JB Chemicals & Pharmaceuticals Ltd is not traded on BSE/NSE
NSE
1697.05
-3.5 %-61.6
BSE
1704.50
-3.27 %-57.6

Ratios

Parameter MAR 21  MAR 20  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)57.9635.2064.66
   CEPS(Rs)66.9243.8352.69
   DPS(Rs)16.5011.0050.00
   Book NAV/Share(Rs)234.17185.7526.07
   Tax Rate(%)24.8621.9313.36
Margin Ratios
   Core EBITDA Margin(%)27.2321.2827.99
   EBIT Margin(%)29.5819.8449.06
   Pre Tax Margin(%)29.2219.6648.65
   PAT Margin (%)21.9615.3543.07
   Cash Profit Margin (%)25.3219.0932.67
Performance Ratios
   ROA(%)19.5512.5355.94
   ROE(%)27.6418.6947.94
   ROCE(%)36.5323.7154.10
   Asset Turnover(x)0.890.828.99
   Sales/Fixed Asset(x)1.731.5710.32
   Working Capital/Sales(x)1.692.34-27.56
Efficiency Ratios
   Fixed Capital/Sales(x)0.580.64-9.36
   Receivable days65.6267.22-2.37
   Inventory Days55.5953.314.27
   Payable days43.6738.7412.73
Valuation Parameters
   PER(x)21.6314.4449.76
   PCE(x)18.7311.6061.50
   Price/Book(x)5.352.7495.61
   Yield(%)1.322.16-39.17
   EV/Net Sales(x)4.742.21114.39
   EV/Core EBITDA(x)14.409.1757.14
   EV/EBIT(x)16.0411.1543.83
   EV/CE(x)3.771.9593.45
   M Cap / Sales4.742.21114.27
Growth Ratio
   Net Sales Growth(%)15.098.0088.51
   Core EBITDA Growth(%)57.0223.38143.90
   EBIT Growth(%)71.5520.75244.87
   PAT Growth(%)64.6640.4359.93
   EPS Growth(%)64.6645.9940.59
Financial Stability Ratios
   Total Debt/Equity(x)0.020.02-12.20
   Current Ratio(x)2.762.4711.59
   Quick Ratio(x)2.251.9416.11
   Interest Cover(x)83.43108.09-22.82
   Total Debt/Mcap(x)0.000.01-55.12

About JB Chemicals & Pharmaceuticals Ltd.

JB Chemicals & Pharmaceuticals Ltd. was incorporated in the year 1976. Its today's share price is 1704.5. Its current market capitalisation stands at Rs 13172.73 Cr. In the latest quarter, company has reported Gross Sales of Rs. 18919.96 Cr and Total Income of Rs.20079.19 Cr. The company's management includes Sandeep Phadnis, Ananya Tripathi, Nikhil Chopra, Prashant Kumar, Gaurav Trehan, Sanjay Nayar, Padmini Khare Kaicker, Sumit Bose, Ranjit Shahani.

It is listed on the BSE with a BSE Code of 506943 , NSE with an NSE Symbol of JBCHEPHARM and ISIN of INE572A01028. It's Registered office is at Neelam Centre, ' B 'wing,4th Floor ,Hind Cycle Road, WorliMumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Damania & Varaiya, Deloitte Haskins & Sells LLP, DNV & Co, JK Shah & Co

Latest News

close